Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Tra...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
At Caris, we understand that cancer is an ugly word—a word no one wants to hear, but one that connects...
Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development.
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.
